BASi® | Docetaxel Heparin Human Plasma Ultrafiltrate

Analyte	Species	Matrix	Anticoagulant	Instrument	Aliquot Volume	LLOQ-ULOQ	Storage Temperature	Status
Docetaxel	Human	Plasma Ultrafiltrate	Heparin	LC-MS/MS	40 µl	2-100 ng/mL	-20 and/or -80 °C	Not Active

Analyte	Docetaxel
Species	Human
Matrix	Plasma Ultrafiltrate
Anticoagulant	Heparin
Instrument	LC-MS/MS
Aliquot Volume	40 µl
LLOQ-ULOQ	2-100 ng/mL
Storage Temperature	-20 and/or -80 °C
Status	Not Active

Tags: chemotherapy cancer taxane semi-synthetic paclitaxel analogue Docefrez® Taxotere®

Example in Scientific Literature

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

BASi Method Number SAP.791

Back to all Assays